BALTIMORE, Nov. 2, 2022
/PRNewswire/ -- Medifast (NYSE: MED), the global company
behind one of the fastest-growing health and wellness communities,
OPTAVIA®, today announced it was recognized by Euromonitor
International, an independent market research firm. According to
Euromonitor, Medifast's OPTAVIA Program was Named #1 Weight
Loss Program in the U.S. by Revenue for 2021.*
Drawn from insights based on Medifast's 40 years of scientific
and clinical heritage, the OPTAVIA program was designed as a
holistic approach for consumers looking for a lifestyle solution,
often starting with weight management and healthy eating. This
evidence-based approach to health and wellbeing sets it apart from
both traditional commercial weight loss programs and app-based
solutions.
"We offer a simple yet comprehensive solution that helps
consumers build healthy habits," said Dan
Chard, Chairman and Chief Executive Officer of Medifast.
"OPTAVIA has impacted more than two million lives through
our approach that typically begins with weight loss but often
serves as a catalyst for greater lifestyle changes. In the past
five years, full-year revenue has increased by more than 455%. We
are now looking to carve our path toward the larger health and
wellness market and transform even more lives."
The fast-growing health and wellness company's revenue has
consistently grown year-over-year – going from $501 million in 2018 to $1.526 billion in 2021 when OPTAVIA joined
a select group of billion-dollar brands. Rising demand for
OPTAVIA resulted in its independent OPTAVIA Coaches
supporting over one million Clients in the last 12 months, as the
majority of U.S. adults consider their health to be a top priority
in life.**
Medifast will announce financial results for the third quarter,
which ended September 30, 2022, on
Thursday, November 3, 2022, at
4:30 p.m. ET. The conference call
will be broadcast live over the Internet, hosted on the Investor
Relations section of Medifast's website at MedifastInc.com or
directly here, and will be archived online and available through
November 17, 2022. To join via
telephone, listeners may dial (855) 560-2579. A telephonic playback
will be available from 6:30 p.m. ET,
November 3, 2022, through
November 10, 2022. Participants can
dial (877) 344-7529 to hear the playback and enter passcode
5231199.
About Medifast:
Medifast (NYSE: MED) is the
global company behind one of the fastest-growing health and
wellness communities, OPTAVIA®, which offers scientifically
developed products, clinically proven plans and the support of
independent OPTAVIA Coaches and a Community to help
Customers achieve Lifelong Transformation, One Healthy Habit at a
Time®. As the publicly traded market leader by revenue in the U.S.
$7 billion weight management
industry, the company has impacted more than 2 million lives
through its Community of OPTAVIA Coaches, who teach
Customers how to develop holistic healthy habits through the
proprietary Habits of Health® Transformational System. Medifast was
recognized in 2022 as one of America's Best Mid-Sized Companies by
Forbes, in 2020 and 2021 as one of FORTUNE's 100 Fastest-Growing
Companies and was named to Forbes' 100 Most Trustworthy
Companies in America list in 2017. For more information, visit
MedifastInc.com or OPTAVIA.com and follow
@Medifast on Twitter.
*Source Euromonitor International Limited;
based on custom research conducted in Q2/2022; value sales for
structured weight loss and meal replacement programs in
2021.
**Methodology: This online survey of 2,000 U.S. adults was
commissioned by Medifast and conducted by market research company
OnePoll, in accordance with the Market Research Society's code of
conduct. Data was collected between April 21
and April 22, 2022. All participants are paid an amount
depending on the length and complexity of the survey. This survey
was overseen and edited by the OnePoll research team, who are
members of the MRS and have corporate membership to ESOMAR and
AAPOR.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/medifasts-optavia-program-named-1-weight-loss-program-in-the-us-by-revenue-for-2021-301665593.html
SOURCE Medifast